AnalystsBruce D. JacksonBruce D. Jackson's Stock Forecasts
AnalystsBruce D. Jackson
Sectors:
Analyst Ranking
Top 35%
#1780 out of 5209 analysts
Average Return
+19.33%
Win Rate
56%5 out of 9
Risk vs Reward
Poor
Good
Bruce D. Jackson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Unicycive Therapeutics IncUNCY | +79.44% | $3.94 | $7.07 | 2025-09-14 - 2026-03-04 | Buy |
Belite Bio IncBLTE | +67.88% | $105.91 | $177.79 | 2025-10-30 - 2026-03-04 | Strong Buy |
Exact Sciences CorpEXAS | +48.73% | $69.59 | $103.50 | 2025-11-03 - 2026-03-04 | Strong Buy |
Harvard Bioscience IncHBIO | +27.84% | $0.45 | $0.57 | 2025-09-09 - 2026-03-04 | Buy |
Humacyte IncHUMA | +17.35% | $0.98 | $1.15 | 2026-01-20 - 2026-03-04 | Strong Buy |
Bruce D. Jackson Analyst Color
Get additional color on Bruce D. Jackson's coverage of popular stocks
Bruce D. Jackson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Humacyte IncHUMA | 2 | Strong Buy | $10.00 | +769.57% | Maintains | a month ago |
Milestone Scientific IncMLSS | 1 | Buy | $1.00 | +246.02% | Maintains | 3 months ago |
Exact Sciences CorpEXAS | 1 | Strong Buy | $75.00 | -27.54% | Maintains | 4 months ago |
Belite Bio IncBLTE | 1 | Strong Buy | $132.00 | -25.76% | Maintains | 4 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 1 | Buy | $7.00 | +2,768.85% | Maintains | 6 months ago |
Unicycive Therapeutics IncUNCY | 1 | Buy | $21.00 | +197.03% | Maintains | 6 months ago |
Harvard Bioscience IncHBIO | 1 | Buy | $2.00 | +248.43% | Maintains | 6 months ago |
Clene IncCLNN | 1 | Strong Buy | $31.00 | +462.61% | Maintains | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.